Serum IgG and mucosal IgA antibodies from pre-pandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
<strong>Objectives<br></strong> Many regions of Africa have experienced lower COVID-19 morbidity and mortality than Europe. Pre-existing humoral responses to endemic human coronaviruses (HCoV) may cross-protect against SARS-CoV-2. We investigated the neutralizing capacity of SARS-C...
Auteurs principaux: | Nyagwange, J, Kutima, B, Mwai, K, Karanja, HK, Gitonga, JN, Mugo, D, Sein, Y, Wright, D, Omuoyo, DO, Nyiro, JU, Tuju, J, Nokes, DJ, Agweyu, A, Bejon, P, Ochola-Oyier, LI, Scott, JAG, Lambe, T, Nduati, E, Agoti, C, Warimwe, GM |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2022
|
Documents similaires
-
Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro
par: James Nyagwange, et autres
Publié: (2023-02-01) -
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations
par: Nyagwange, J, et autres
Publié: (2021) -
The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya.
par: Rachel Ochola, et autres
Publié: (2009-12-01) -
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
par: Uyoga, S, et autres
Publié: (2021) -
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21
par: Lucinde, RK, et autres
Publié: (2022)